Prolonged myocardial ischemia after intravenous dipyridamole thallium imaging

Journal Article · Mon Nov 30 23:00:00 EST 1987 · Chest; (United States)

DOI:https://doi.org/10.1378/chest.92.6.1102· OSTI ID:5602869

Lewen, M K; Labovitz, A J; Kern, M J; Chaitman, B R

Intravenous dipyridamole thallium imaging is reported to be a safe test with minimal side effects. It has been proposed by some that the test simply dilates the coronary vessels without actually producing myocardial ischemia. In this report, we describe a patient who, following intravenous dipyridamole thallium imaging, developed severe myocardial ischemia which persisted for 90 minutes, requiring emergency coronary angioplasty to alleviate the ischemic insult. Sequential electrocardiograms and cardiac isoenzyme levels following coronary angioplasty were within normal limits. Thus, severe myocardial ischemia following intravenous dipyridamole testing can occur and emphasizes the importance of careful monitoring of these patients, particularly when the pretest risk of coronary disease is high.

• Research Organization: St. Louis Univ. Medical Center, MO
• OSTI ID: 5602869
• Journal Information: Chest; (United States), Journal Name: Chest; (United States) Vol. 92:6; ISSN CHETB
• Country of Publication: United States
• Language: English

Related Subjects

560151* -- Radiation Effects on Animals-- Man
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ARTERIES
BLOOD VESSELS
BODY
CARDIOVASCULAR AGENTS
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
CORONARIES
COUNTING TECHNIQUES
DIAGRAMS
DISEASES
DRUGS
ELECTROCARDIOGRAMS
HEART
ISCHEMIA
MEDICINE
MUSCLES
MYOCARDIUM
ORGANS
PATIENTS
RADIOINDUCTION
RADIOISOTOPE SCANNING
SIDE EFFECTS
SURGERY
VASCULAR DISEASES
VASODILATORS